Liver Injury Associated with Antituberculosis Medications
Tuberculosis remains a major global health concern, with a sharp increase in new cases in 2022, exceeding the prevalence before the coronavirus disease 2019 (COVID-19) pandemic. Conventional antituberculosis therapy, comprising a combination of first-line medications, is essential for controlling tu...
Saved in:
| Main Authors: | Syifa Mustika, Lia Susanti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Faculty of Medicine, Universitas Airlangga
2025-07-01
|
| Series: | Current Internal Medicine Research and Practice Surabaya Journal |
| Subjects: | |
| Online Access: | https://e-journal.unair.ac.id/CIMRJ/article/view/66980 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk Factors of Antituberculosis Induced-Hepatotoxicity among HIV/AIDS Patients
by: Lies Luthariana, et al.
Published: (2017-03-01) -
Exploring drug-induced liver injury: comprehensive insights into mechanisms and management of hepatotoxic agents
by: Ahmed K. Saleh, et al.
Published: (2025-03-01) -
Hepatotoxicity Associated with Adalimumab in Hidradenitis Suppurativa: A Report of Two Cases of Drug-Induced Liver Injury
by: Cristian Fernando Caballero-Linares, et al.
Published: (2025-07-01) -
Hepatotropic Therapy in Treatment of Liver Injury
by: D. S. Sukhanov, et al.
Published: (2020-05-01) -
Hepatotoxicity evaluation of cannabidiol, cannabinol, cannabichromene and cannabigerol using a human quad culture liver chip
by: Jacob D. Larson, et al.
Published: (2025-08-01)